Brief: Willow Biosciences Reports Fourth Quarter And 2020 Year End Results And Operational Update

Atlas Energy

24/03/2021 02:50

March 23 (Reuters) - Willow Biosciences Inc  WLLW.TO :
    * WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND 2020 YEAR
END
RESULTS AND OPERATIONAL UPDATE
    * ON TRACK TO COMMERCIALIZE ITS FIRST CANNABINOID, CBG, IN
Q1 2021
    * FIRST SALES OF CBG EXPECTED TO OCCUR IN Q2 2021
    * DURING REMAINDER OF 2021, WILLOW WILL CONTINUE TO OPTIMIZE
ITS
COMMERCIAL PROCESS FOR CBG
    * EXPECTS 2022 TO BE CBG'S FIRST FULL YEAR OF COMMERCIAL
PRODUCTION AND SALES
    * WILLOW BIOSCIENCES  -  PLANS TO UPDATE MARKET ON WHICH
CANNABINOID IT INTENDS TO COMMERCIALIZE NEXT LATER THIS YEAR AND
INTO 2022

Source text for Eikon:  ID:nCNWTckBNa 
Further company coverage:  WLLW.TO 

 ((Reuters.Briefs@thomsonreuters.com;))